Chugai Pharmaceutical Co Ltd 4519.T-JP:Tokyo Stock Exchange

*Data is delayed | JPY
Last | 3:00 PM JST
4,769.00quote price arrow up+6.00 (+0.13%)
Volume
1,953,000
52 week range
3,173.30 - 6,435.00

...

Loading . . .

KEY STATS

  • Open4,833.00
  • Day High4,871.00
  • Day Low4,733.00
  • Prev Close4,763.00
  • 52 Week High6,435.00
  • 52 Week High Date01/12/21
  • 52 Week Low3,173.30
  • 52 Week Low Date03/13/20
  • Market Cap73,599.72M
  • Shares Out1,643.87M
  • 10 Day Average Volume2.04M
  • Dividend60.00
  • Dividend Yield1.26%
  • Beta
  • 1 Year % Change22.13

RATIOS/PROFITABILITY

  • EPS (TTM)138.10
  • P/E (TTM)34.53
  • Fwd P/E (NTM)-
  • EBITDA (MRQ)-
  • ROE (MRQ)-
  • Revenue (MRQ)-
  • Gross Margin (MRQ)-
  • Net Margin (MRQ)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date12/29/2020
  • Div Amount30.00
  • Split Date-
  • Split Factor-

Latest Chugai Pharmaceutical Co Ltd News

There is no recent news for this security.

QUOTE FINDER

Profile

MORE
CHUGAI PHARMACEUTICAL CO., LTD. is a Japan-based company mainly engaged in the research, development, manufacture, sale, import and export of pharmaceutical products. The pharmaceutical products and medical devices for patients include ACTEMRA, Avastin, ALAGLIO, Aresensa, Kadosaira, Gazaiba, Seruseputo, Zeruborafu, Zeroda, Taruseba, Tecentoriku, Pajeta and other products. The products are mainly applied to the treatment of cancer, kidney diseases, kidney transplantation, bone...
Tatsuro Kosaka
Chairman
Motoo Ueno
Vice Chairman
Osamu Okuda
President
Toshiaki Itagaki
Chief Financial Officer
Shinya Unno
Executive Vice President
Address
15F, Nihonbashi Mitsui Tower
2-1-1, Nihonbashi-Muro-machi
Chuo-ku, TKY
103-8324
Japan